Printer Friendly

STAAR SURGICAL COMPANY RECEIVES CANADIAN APPROVAL FOR ITS ELASTIC(TM) LENS

 MONROVIA, Calif., June 4 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) announced today the approval of its ELASTIC(TM) lens for general distribution in Canada by the Health Protection Branch ("HPB"), the regulatory agency for Canadian pharmaceuticals and devices.
 STAAR's ELASTIC(TM) lens is the world's first single piece foldable intraocular lens ("IOL") which is fully injectable through a micro surgical incision. Foldable micro incision lenses are projected by market analysts to dominate the IOL marketplace within the next five years, and STAAR is the owner of a broad patent covering all deformable IOL's.
 "This approval is indicative of the continuation of STAAR's global market and regulatory expansion," said John R. Wolf, president and CEO.
 "The approval of our ELASTIC(TM) lens gives us commercial market entry into Canada which is among the top five markets for medical products in the world. This approval should facilitate future acceptance of our more advanced products as they are filed with HPB and other global regulatory agencies."
 STAAR Surgical Company, a publicly traded corporation founded in 1982, develops, manufactures and markets products for micro incision ophthalmic surgery, primarily for use in cataract procedures. All of STAAR's primary products are approved by the FDA.
 -0- 6/4/93
 /CONTACT: William Roberts (investor relations) of Cameron Towey Central, 513-469-0202; or Jane Ingalls (media relations) of Sawyer/Miller Group, 212-484-7558; both for STAAR Surgical/
 (STAA)


CO: STAAR Surgical Company ST: California IN: MTC SU:

BM -- CL003 -- 5329 06/04/93 09:06 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 4, 1993
Words:246
Previous Article:CHARTER FEDERAL ANNOUNCES RIGHTS OFFERING
Next Article:JOHN N. LAUER TO RECEIVE 1993 DISTINGUISHED ENGINEERING ALUMNUS AWARD FROM THE UNIVERSITY OF MARYLAND AT COLLEGE PARK
Topics:


Related Articles
STAAR SURGICAL ANNOUNCES FDA APPROVAL OF 'UV' MATERIAL
STAAR Surgical Introduces First Intraocular Lens Implant To Treat Cataracts and Astigmatism.
First STAAR Surgical TORIC ICL Lens Implanted.
STAAR Surgical Company Receives European CE Mark for the Collamer IOLs; Approval Clears Way for Marketing STAAR's Collamer IOL Throughout the...
STAAR Surgical Expands Presence in Refractive Market; Company to Open up to 20 STAAR Laser Centers by the End of 2000.
STAAR Surgical Company Receives Approval to Market the Collamer IOL in Canada.
STAAR Surgical Receives FDA Approval to Market The Collamer IOL in United States.
Initial U.S. Release of STAAR Surgical's Collamer IOL Exceeds Expectations.
STAAR Surgical Receives One-Piece Collamer(TM) Manufacturing Clearance.
Health Canada Issues License for STAAR Surgical's AquaFlow(TM).

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters